HOME
ABOUT US
ARCHIVE
ADVERTISE
CONTACT
BLOG
RSS FEED
SEARCH
AMERICAN.COM
The Journal of the American Enterprise Institute
Email the editor
Is Competition Coming?
By
THE AMERICAN
03/21/2008
Geoffrey Allan, CEO of biotechnology firm Insmed, discusses the benefits of generic competition for biologic drugs.
Your name:
(Required)
Your email address:
(Required)
Message
(Required)